Correlation  ||| S:0 E:12 ||| NN
between  ||| S:12 E:20 ||| IN
Charlson  ||| S:20 E:29 ||| NNP
comorbidity  ||| S:29 E:41 ||| JJ
index  ||| S:41 E:47 ||| NN
and  ||| S:47 E:51 ||| CC
outcome  ||| S:51 E:59 ||| NN
in  ||| S:59 E:62 ||| IN
patients  ||| S:62 E:71 ||| NNS
with  ||| S:71 E:76 ||| IN
chronic  ||| S:76 E:84 ||| JJ
phase  ||| S:84 E:90 ||| NN
chronic  ||| S:90 E:98 ||| NN
myeloid  ||| S:98 E:106 ||| NNS
leukemia  ||| S:106 E:115 ||| VBP
treated  ||| S:115 E:123 ||| VBN
with  ||| S:123 E:128 ||| IN
second-generation  ||| S:128 E:146 ||| FW
tyrosine  ||| S:146 E:155 ||| FW
kinase  ||| S:155 E:162 ||| FW
inhibitors  ||| S:162 E:173 ||| FW
upfront  ||| S:173 E:182 ||| FW
